BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1321 | Download: 1496
Publication Name World Journal of Clinical Oncology
Manuscript ID 8443
Country Greece
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen
Manuscript Source Invited Manuscript
All Author List Christos Markopoulos, Stylianos Kykalos and Dimitrios Mantas
Funding Agency and Grant Number
Corresponding Author Christos Markopoulos, MD, Professor of Surgery, Breast Unit, 2nd Propedeutic Department of Surgery, Faculty of Medicine, National and Kapodistrian University of Athens, 8, Iassiou street, 11521 Athens, Greece. cmarkop@hol.gr
Key Words CYP2D6; Tamoxifen; Breast cancer; Adjuvant treatment
Core Tip Currently, routine cytochrome P450 (CYP)2D6 testing among women with breast cancer is not recommended and the significance of CYP2D6 phenotype in decision making regarding the administration of tamoxifen is unclear. The present study summarizes current literature regarding clinical studies on CYP2D6*4, particularly in terms of response to tamoxifen therapy and breast cancer outcome.
Publish Date 2014-08-01 15:17
Citation KMarkopoulos C, Kykalos S, Mantas D. Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen. World J Clin Oncol 2014; 5(3): 374-381
URL http://www.wjgnet.com/2218-4333/full/v5/i3/374.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i3.374
Full Article (PDF) WJCO-5-374.pdf
Full Article (Word) WJCO-5-374.doc